CLINICAL TRIALS PROFILE FOR ACETIC ACID 0.25% IN PLASTIC CONTAINER
✉ Email this page to a colleague
All Clinical Trials for Acetic Acid 0.25% In Plastic Container
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00003697 ↗ | Dimethylxanthenone Acetic Acid in Treating Patients With Solid Tumors | Completed | University of Glasgow | Phase 1 | 1995-10-01 | RATIONALE: Dimethylxanthenone acetic acid may stop the growth of cancer cells by stopping blood flow to the tumor. PURPOSE: Phase I trial to study the effectiveness of dimethylxanthenone acetic acid in treating patients with solid tumors that have not responded to previous therapy. |
NCT00044213 ↗ | Trial to Assess Chelation Therapy (TACT) | Completed | National Center for Complementary and Integrative Health (NCCIH) | Phase 3 | 2003-09-01 | The purpose of this study is to determine the safety and effectiveness of ethylene diamine tetra-acetic (EDTA) chelation therapy in individuals with coronary artery disease. |
NCT00044213 ↗ | Trial to Assess Chelation Therapy (TACT) | Completed | National Heart, Lung, and Blood Institute (NHLBI) | Phase 3 | 2003-09-01 | The purpose of this study is to determine the safety and effectiveness of ethylene diamine tetra-acetic (EDTA) chelation therapy in individuals with coronary artery disease. |
NCT00044213 ↗ | Trial to Assess Chelation Therapy (TACT) | Completed | Mt. Sinai Medical Center, Miami | Phase 3 | 2003-09-01 | The purpose of this study is to determine the safety and effectiveness of ethylene diamine tetra-acetic (EDTA) chelation therapy in individuals with coronary artery disease. |
NCT00051545 ↗ | Seocalcitol Versus Placebo in the Adjuvant Treatment of Hepatocellular Carcinoma | Terminated | LEO Pharma | Phase 3 | 1999-11-01 | To evaluate the efficacy of Seocalcitol in prolonging time to relapse following intended curative resection or percutaneous ablative treatment, i.e. percutaneous ethanol injection(s), percutaneous acetic acid injection(s), percutaneous microwave coagulation therapy, or percutaneous radiofrequency ablation for hepatocellular carcinoma (HCC). |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Acetic Acid 0.25% In Plastic Container
Condition Name
Condition Name for Acetic Acid 0.25% In Plastic Container | |
Intervention | Trials |
Cervical Cancer | 3 |
Unspecified Adult Solid Tumor, Protocol Specific | 3 |
Extensive Stage Small Cell Lung Cancer | 2 |
Hepatic Encephalopathy | 2 |
[disabled in preview] | 0 |
This preview shows a limited data set Subscribe for full access, or try a Trial |
Clinical Trial Locations for Acetic Acid 0.25% In Plastic Container
Trials by Country
Clinical Trial Progress for Acetic Acid 0.25% In Plastic Container
Clinical Trial Phase
Clinical Trial Sponsors for Acetic Acid 0.25% In Plastic Container
Sponsor Name